Similarly to NEK7, SOX4 has been identified as an important oncogene in a variety of other cancers including endometrial cancer [31], brain cancer [32,33], breast cancer [34], bladder cancer [35], ovarian cancer [36], colorectal cancer [37], liver cancer [30] and leukemia [38]. This evidence concerns the gene NEK7 and urinary bladder cancer.